Kindred Healthcare Inc. (KND) Financials Nov 20, 2014, 4:33
Kindred Healthcare Inc. (KND) Financials Nov 20, 2014, 4:33 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Kindred Healthcare Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 4.27B 4.36B 5.52B 6.18B 4.9B
Cost of Goods Sold (COGS) incl. D&A 4.18B 3.92B 5.34B 5.97B 4.78B
COGS excluding D&A 4.05B 3.8B 5.17B 5.76B 4.59B
Depreciation & Amortization Expense 126.4M 121.55M 165.59M 201.48M 182.39M
Depreciation 124.8M 120.3M 152.2M 179.1M 135.2M
Amortization of Intangibles 1.6M 1.25M 13.39M 22.38M 47.19M
Gross Income 93.68M 441.65M 186M 215.83M 123.84M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense - - - - -
Research & Development - - - - -
Other SG&A - - - - -
Other Operating Expense 0 357.37M 0 0 0
Unusual Expense (11.51M) (11.42M) 179.18M 113.06M 79.29M
EBIT after Unusual Expense 11.51M 11.42M (179.18M) (113.06M) (79.29M)
Non Operating Income/Expense 0 0 9.69M 10.81M 1.44M
Non-Operating Interest Income 4.41M 1.25M 1.03M 1.05M 4.05M
Equity in Affiliates (Pretax) 0 0 0 0 0
Interest Expense 7.88M 7.09M 80.92M 107.9M 108.05M
Gross Interest Expense 10.08M 8.39M 82.42M 110.3M 108.15M
Interest Capitalized 2.2M 1.3M 1.5M 2.4M 100,000
Pretax Income 101.73M 89.85M (63.38M) 6.74M (58.02M)
Income Tax 39.12M 33.71M (7.1M) 39.11M (13.2M)
Income Tax - Current Domestic 27.47M 14.85M (6.55M) 51.49M 0
Income Tax - Current Foreign - - - - -
Income Tax - Deferred Domestic 11.64M 18.85M (553,000) (12.38M) (13.2M)
Income Tax - Deferred Foreign - - - - -
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) (701,000) (1.02M) 0 0 0
Consolidated Net Income 61.91M 55.13M (56.27M) (32.37M) (44.81M)
Minority Interest Expense 0 0 (238,000) 1.04M 3.66M
Net Income 61.91M 55.13M (56.03M) (33.41M) (48.47M)
Extraordinaries & Discontinued Operations (22.5M) 345,000 2.55M (6.95M) (120.02M)
Extra Items & Gain/Loss Sale Of Assets (23.43M) (453,000) 0 (4.75M) (83.89M)
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 931,000 798,000 2.55M (2.21M) (36.14M)
Net Income After Extraordinaries 39.41M 55.47M (53.48M) (40.37M) (168.49M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 61.91M 55.13M (56.03M) (33.41M) (48.47M)
EPS (Basic) 1.64 1.44 (1.16) (0.69) (1.62)
Basic Shares Outstanding 38.34M 38.74M 46.28M 51.66M 52.25M
EPS (Diluted) 1.63 1.44 (1.16) (0.69) (1.62)
Diluted Shares Outstanding 38.5M 38.95M 46.28M 51.66M 52.25M
EBITDA 220.09M 205.83M 351.6M 417.31M 306.22M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...
Continue Reading
Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...
Continue Reading
Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...
Continue Reading
Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....
Continue Reading
ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...
Continue Reading
Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...
Continue Reading
China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...
Continue Reading
Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...
Continue Reading
Top 5 Most Recently Viewed Articles
Welcome to New Beginnings in North Dakota As the season of relocation kicks off, North Dakota is inviting jobseekers with its innovative campaign, Find the Good Life in North Dakota. This initiative coincides with National Moving Day, marking the start of a bustling season when many families seek new horizons across the country. Embrace New Opportunities "People are on...
Continue Reading
Celebrating Industry Recognition Caseware™, a pioneer in AI-enabled audit, financial reporting, and data analytics, has recently basked in a wave of industry accolades. These recognitions underscore the company's unmatched leadership in driving innovation and delivering impactful solutions to accounting professionals worldwide. A Double Triumph for Caseware In a...
Continue Reading
Telomir Pharmaceuticals Sees Significant Pre-market Surge Shares of Telomir Pharmaceuticals Inc (NASDAQ: TELO) experienced a remarkable increase of 31%, reaching $1.86 in pre-market trading. This boost comes in the wake of encouraging preclinical results regarding their primary compound, Telomir-1. Promising Preclinical Study Results The biotechnology firm disclosed these...
Continue Reading
Market Overview for Potential Rebounds The stock market is often unpredictable, with certain stocks experiencing declines even after positive earnings reports. In recent times, some stocks have evidently fallen out of favor with investors, particularly following disappointing earnings or cautious guidance from companies. Interestingly, stocks with low expectations can...
Continue Reading
Acer Inc. Demonstrates Strong Quarter Over Quarter Growth Acer Inc. (TWSE: 2353) has recently shared impressive financial results for the third quarter of 2024, showcasing resilience and growth in a competitive market. The company reported consolidated revenues of NT$72.69 billion, reflecting an 8.3% increase compared to the previous quarter and a 7.8% rise year-on-year....
Continue Reading